IUASX
Price
$42.60
Change
-$0.31 (-0.72%)
Updated
Jun 13 closing price
Net Assets
449.69M
RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

IUASX vs RLBGX

Header iconIUASX vs RLBGX Comparison
Open Charts IUASX vs RLBGXBanner chart's image
VY® Invesco Equity and Income S
Price$42.60
Change-$0.31 (-0.72%)
VolumeN/A
Net Assets449.69M
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
IUASX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IUASX vs. RLBGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IUASX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. IUASX (450M). IUASX pays higher dividends than RLBGX: IUASX (3.14) vs RLBGX (2.23). IUASX was incepted earlier than RLBGX: IUASX (24 years) vs RLBGX (16 years). IUASX (0.99) is less costly to investors than RLBGX (0.25). IUASX is a more actively managed with annual turnover of: 125.00 vs. RLBGX (44.00). IUASX has a lower initial minimum investment than RLBGX: IUASX (0) vs RLBGX (250). RLBGX annual gain was more profitable for investors over the last year : 5.63 vs. IUASX (1.71). RLBGX return over 5 years is better than : 40.35 vs. IUASX (17.61).
IUASXRLBGXIUASX / RLBGX
Total Expense Ratio0.890.25356%
Annual Report Gross Expense Ratio0.990.25396%
Fund Existence24 years16 years-
Gain YTD2.4284.59253%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets450M244B0%
Annual Yield % from dividends3.142.23141%
Returns for 1 year1.715.6330%
Returns for 3 years-0.7733.78-2%
Returns for 5 years17.6140.3544%
Returns for 10 years7.5160.8712%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp